首页|重复经颅磁刺激治疗脑梗死后偏瘫患者的效果

重复经颅磁刺激治疗脑梗死后偏瘫患者的效果

扫码查看
目的:观察重复经颅磁刺激(rTMS)治疗脑梗死后偏瘫患者的效果.方法:回顾性分析 2021 年 1 月至 2023 年 1 月该院收治的 96 例脑梗死后偏瘫患者的临床资料,按照治疗方案不同分为观察组和对照组各 48 例.对照组予以常规治疗,观察组在对照组基础上给予rTMS治疗,比较两组临床疗效、美国国立卫生研究院卒中量表(NIHSS)评分、Fugl-Meyer运动功能量表(FMA)评分、Barthel指数(BI)评分、血清神经功能指标[脑钠肽(BNP)、S100β蛋白、神经元特异性烯醇化酶(NSE)]水平、血清炎性因子[白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、超敏C反应蛋白(hs-CRP)]水平、氧化应激指标[血清超氧化物歧化酶(SOD)、丙二醛、谷胱甘肽过氧化物酶(GSH-Px)]水平和不良反应发生率.结果:观察组治疗总有效率为 91.67%,高于对照组的 75.00%,差异有统计学意义(P<0.05);治疗后,观察组NIHSS评分,血清BNP、NSE、S100β、IL-6、TNF-α、hs-CRP和丙二醛水平低于对照组,上肢FMA评分、下肢FMA评分、BI评分和血清SOD、GSH-Px水平高于对照组,差异均有统计学意义(P<0.05);治疗期间,两组均无明显不良反应.结论:在常规治疗基础上采用rTMS治疗脑梗死后偏瘫患者可提高治疗总有效率、FMA评分和BI评分,改善氧化应激指标水平,降低NIHSS评分、血清神经功能指标水平和血清炎性因子水平,效果优于单纯常规治疗.
Effects of rTMS in treatment of patients with hemiplegia after cerebral infarction
Objective:To observe effects of repetitive transcranial magnetic stimulation(rTMS)on patients with hemiplegia after cerebral infarction.Methods:The clinical data of 96 patients with hemiplegia after cerebral infarction admitted to this hospital from January 2021 to January 2023 were retrospectively analyzed.According to the different treatment plans,they were divided into observation group and control group,48 cases in each group.The control group was given routine treatment,while the observation group was given rTMS treatment on the basis of that of the control group.The clinical efficacy,the National Institutes of Health stroke scale(NIHSS)score,the Fugl-Meyer motor assessment(FMA)score,the Barthel index(BI)score,the serum neurological function indexes[brain natriuretic peptide(BNP),S100β protein,neuron-specific enolase(NSE)]levels,the serum inflammatory factors[interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),hypersensitive C-reactive protein(hs-CRP)]levels,the oxidative stress indexes[serum superoxide dismutase(SOD),malondialdehyde,glutathione peroxidase(GSH-Px)]levels,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 91.67%,which was higher than 75.00%of the control group,and the difference was statistically significant(P<0.05).After the treatment,the NIHSS score,the levels of BNP,NSE,S100β protein,IL-6,TNF-α,hs-CRP,and MDA level in the observation group were lower than those in the control group;the upper limb FMA score,the lower limb FMA score,the BI score and the serum SOD and GSH-Px levels were higher than those in the control group;and the differences were statistically significant(P<0.05).During the treatment,there were no obvious adverse reactions in the two groups.Conclusions:On the basis of the routine treatment,rTMS treatment can improve the total effective rate,the FMA scores and the BI scores,improve the levels of oxidative stress indexes,and reduce the NIHSS scores,the serum neurological function index and serum inflammatory factor levels in the patients with hemiplegia after cerebral infarction.Moreover,it is superior to single routine treatment.

Cerebral infarctionHemiplegiaRepetitive transcranial magnetic stimulationOxidative stressFMA scoreBI score

白冰

展开 >

三门峡市第三人民医院神经内科,河南 三门峡 472100

脑梗死 偏瘫 重复经颅磁刺激 氧化应激 FMA评分 BI评分

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(10)
  • 8